PAPA-DEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Papa-deine, and when can generic versions of Papa-deine launch?
Papa-deine is a drug marketed by Vangard and is included in two NDAs.
The generic ingredient in PAPA-DEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Papa-deine
A generic version of PAPA-DEINE was approved as acetaminophen; codeine phosphate by SUN PHARM INDS LTD on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PAPA-DEINE?
- What are the global sales for PAPA-DEINE?
- What is Average Wholesale Price for PAPA-DEINE?
Summary for PAPA-DEINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | PAPA-DEINE at DailyMed |
US Patents and Regulatory Information for PAPA-DEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vangard | PAPA-DEINE #3 | acetaminophen; codeine phosphate | TABLET;ORAL | 088037-001 | Mar 20, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vangard | PAPA-DEINE #4 | acetaminophen; codeine phosphate | TABLET;ORAL | 088715-001 | Mar 20, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
